Close Menu

NEW YORK – The European Commission has awarded a team of researchers €3 million ($3.3 million) to develop diagnostic tools for infectious disease testing.

The project, called "Towards an instrument-free future of molecular diagnostics at the point-of-care," has been funded through the EC's Horizon 2020 program. It is set to commence in January 2020 and run through the end of 2022. Investigators at the Foundation for Research and Technology - Hellas (FORTH), a Greek research institute, are coordinating the effort.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.